Pancreatic Cancer UK has warned shortages of the drug Creon could last until at least 2026, affecting an estimated 61,152 ...

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion, but has been hard to obtain for the last year and ...

Creon Butler leads the Global Economy and Finance Programme at Chatham House. He joined the institute in 2019, since when he has written and published on a wide range of global economic policy issues, ...

Mick needs creon since being treated for pancreatic cancer in 2023 Cancer patients and others with debilitating conditions have highlighted shortages of a vital drug they say have had a ...

Creon Butler joined Chatham House from the Cabinet Office where he served as director for international economic affairs in the National Security Secretariat and G7/G20 ‘sous sherpa’, advising on ...